PCSK9 Inhibitors in Acute Ischemic Stroke Patients Undergoing Endovascular Therapy

NCT07174375 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

NOT_YET_RECRUITING

Status

478

Enrollment

OTHER

Sponsor class

Conditions

Acute Ischemic Stroke

Interventions

DRUG: PCSK9 inhibitor

Sponsor

Nanfang Hospital, Southern Medical University